Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | MedNEXT Journal of Medical and Health Sciences |
DOI: | 10.54448/mdnt22S104 |
Texto Completo: | https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/148 |
Resumo: | Introduction: Science has evolved at an accelerated pace in the last decades, due to the need to know more and more the human being and the environment that surrounds them. In the search for this knowledge, aiming to improve the quality of life and the treatment of diseases previously considered incurable, research, especially in the field of biotechnology, has transformed the day-to-day health professionals. The application of this biotechnology related to growth factors can be exemplified in the use of platelet-rich plasma (PRP), gel capable of modulating and accelerating some repair processes. Objective: The objective of this work was to review the concepts related to growth factors, as well as in relation to platelet-rich plasma as an adjuvant in bone regeneration therapies. Methods: The present study followed a systematic review model, following the rules of systematic review – PRISMA. This study focuses on the treatment of bone regeneration through platelet-rich plasma and morphogenetic protein (BMP). To this end, a survey was conducted in scientific articles in the databases PubMed, Medline, Scielo, Lilacs, and e-books. The Cochrane Instrument was used to assess the risk of bias of the included studies, and GRADE was used to classify the quality of articles to the type of study and scientific evidence. Results and Conclusion: Therefore, the use of PRP, which would accelerate the rate of bone formation, with bone morphogenetic proteins (BMPs), recombinant or autogenous, should be quite important and elucidative. The development of new research, seeking to use all known technology, will always be the best way for a short future to recognize what should be incorporated into the daily routine of medical and dental clinics, differing from what, for various reasons, whether it was just a marketing procedure or something. The greatest advantage of the use of platelet-rich plasma is its ability to accelerate the process of bone regeneration by increasing the number of growth factors present in human platelets. On the other hand, it is observed that one of its major disadvantages is the low life expectancy of these platelets in the recipient or graft bed. However, it is also known that the PRP technique would only accelerate a process of bone regeneration that normally already occurs and this process follows its path until the formation of the mature bone. |
id |
FACERES-1_b7d3a6e9a1bf7e9f0c480cd62e5d194f |
---|---|
oai_identifier_str |
oai:ojs2.mednext.zotarellifilhoscientificworks.com:article/148 |
network_acronym_str |
FACERES-1 |
network_name_str |
MedNEXT Journal of Medical and Health Sciences |
spelling |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regenerationBone regenerationBone RemodelationPlatelet-rich plasmaBone morphogenetic proteinIntroduction: Science has evolved at an accelerated pace in the last decades, due to the need to know more and more the human being and the environment that surrounds them. In the search for this knowledge, aiming to improve the quality of life and the treatment of diseases previously considered incurable, research, especially in the field of biotechnology, has transformed the day-to-day health professionals. The application of this biotechnology related to growth factors can be exemplified in the use of platelet-rich plasma (PRP), gel capable of modulating and accelerating some repair processes. Objective: The objective of this work was to review the concepts related to growth factors, as well as in relation to platelet-rich plasma as an adjuvant in bone regeneration therapies. Methods: The present study followed a systematic review model, following the rules of systematic review – PRISMA. This study focuses on the treatment of bone regeneration through platelet-rich plasma and morphogenetic protein (BMP). To this end, a survey was conducted in scientific articles in the databases PubMed, Medline, Scielo, Lilacs, and e-books. The Cochrane Instrument was used to assess the risk of bias of the included studies, and GRADE was used to classify the quality of articles to the type of study and scientific evidence. Results and Conclusion: Therefore, the use of PRP, which would accelerate the rate of bone formation, with bone morphogenetic proteins (BMPs), recombinant or autogenous, should be quite important and elucidative. The development of new research, seeking to use all known technology, will always be the best way for a short future to recognize what should be incorporated into the daily routine of medical and dental clinics, differing from what, for various reasons, whether it was just a marketing procedure or something. The greatest advantage of the use of platelet-rich plasma is its ability to accelerate the process of bone regeneration by increasing the number of growth factors present in human platelets. On the other hand, it is observed that one of its major disadvantages is the low life expectancy of these platelets in the recipient or graft bed. However, it is also known that the PRP technique would only accelerate a process of bone regeneration that normally already occurs and this process follows its path until the formation of the mature bone.Faceres2022-04-04info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/otherapplication/pdfhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/14810.54448/mdnt22S104MedNEXT Journal of Medical and Health Sciences; Vol. 3 (2022): MedNEXT - May 2022 - Supplement 1MedNEXT Journal of Medical and Health Sciences; v. 3 (2022): MedNEXT - May 2022 - Supplement 12763-567810.54448/mdnt22S1reponame:MedNEXT Journal of Medical and Health Sciencesinstname:Faculdade de Medicina em São José do Rio Preto (Faceres)instacron:FACERESenghttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/148/139Copyright (c) 2022 MedNEXT Journal of Medical and Health Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessYaguana Galarraga, Daniel AlfonsoRomero Urdiales, Luis AlonsoManzini, Régis2022-05-05T02:52:03Zoai:ojs2.mednext.zotarellifilhoscientificworks.com:article/148Revistahttps://mednext.zotarellifilhoscientificworks.com/index.php/mednextPUBhttps://mednext.zotarellifilhoscientificworks.com/index.php/mednext/oaimednextjmhs@zotarellifilhoscientificworks.com2763-56782763-5678opendoar:2022-05-05T02:52:03MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres)false |
dc.title.none.fl_str_mv |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
title |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
spellingShingle |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration Yaguana Galarraga, Daniel Alfonso Bone regeneration Bone Remodelation Platelet-rich plasma Bone morphogenetic protein Yaguana Galarraga, Daniel Alfonso Bone regeneration Bone Remodelation Platelet-rich plasma Bone morphogenetic protein |
title_short |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
title_full |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
title_fullStr |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
title_full_unstemmed |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
title_sort |
Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration |
author |
Yaguana Galarraga, Daniel Alfonso |
author_facet |
Yaguana Galarraga, Daniel Alfonso Yaguana Galarraga, Daniel Alfonso Romero Urdiales, Luis Alonso Manzini, Régis Romero Urdiales, Luis Alonso Manzini, Régis |
author_role |
author |
author2 |
Romero Urdiales, Luis Alonso Manzini, Régis |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Yaguana Galarraga, Daniel Alfonso Romero Urdiales, Luis Alonso Manzini, Régis |
dc.subject.por.fl_str_mv |
Bone regeneration Bone Remodelation Platelet-rich plasma Bone morphogenetic protein |
topic |
Bone regeneration Bone Remodelation Platelet-rich plasma Bone morphogenetic protein |
description |
Introduction: Science has evolved at an accelerated pace in the last decades, due to the need to know more and more the human being and the environment that surrounds them. In the search for this knowledge, aiming to improve the quality of life and the treatment of diseases previously considered incurable, research, especially in the field of biotechnology, has transformed the day-to-day health professionals. The application of this biotechnology related to growth factors can be exemplified in the use of platelet-rich plasma (PRP), gel capable of modulating and accelerating some repair processes. Objective: The objective of this work was to review the concepts related to growth factors, as well as in relation to platelet-rich plasma as an adjuvant in bone regeneration therapies. Methods: The present study followed a systematic review model, following the rules of systematic review – PRISMA. This study focuses on the treatment of bone regeneration through platelet-rich plasma and morphogenetic protein (BMP). To this end, a survey was conducted in scientific articles in the databases PubMed, Medline, Scielo, Lilacs, and e-books. The Cochrane Instrument was used to assess the risk of bias of the included studies, and GRADE was used to classify the quality of articles to the type of study and scientific evidence. Results and Conclusion: Therefore, the use of PRP, which would accelerate the rate of bone formation, with bone morphogenetic proteins (BMPs), recombinant or autogenous, should be quite important and elucidative. The development of new research, seeking to use all known technology, will always be the best way for a short future to recognize what should be incorporated into the daily routine of medical and dental clinics, differing from what, for various reasons, whether it was just a marketing procedure or something. The greatest advantage of the use of platelet-rich plasma is its ability to accelerate the process of bone regeneration by increasing the number of growth factors present in human platelets. On the other hand, it is observed that one of its major disadvantages is the low life expectancy of these platelets in the recipient or graft bed. However, it is also known that the PRP technique would only accelerate a process of bone regeneration that normally already occurs and this process follows its path until the formation of the mature bone. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-04-04 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion info:eu-repo/semantics/other |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/148 10.54448/mdnt22S104 |
url |
https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/148 |
identifier_str_mv |
10.54448/mdnt22S104 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://mednext.zotarellifilhoscientificworks.com/index.php/mednext/article/view/148/139 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 MedNEXT Journal of Medical and Health Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 MedNEXT Journal of Medical and Health Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Faceres |
publisher.none.fl_str_mv |
Faceres |
dc.source.none.fl_str_mv |
MedNEXT Journal of Medical and Health Sciences; Vol. 3 (2022): MedNEXT - May 2022 - Supplement 1 MedNEXT Journal of Medical and Health Sciences; v. 3 (2022): MedNEXT - May 2022 - Supplement 1 2763-5678 10.54448/mdnt22S1 reponame:MedNEXT Journal of Medical and Health Sciences instname:Faculdade de Medicina em São José do Rio Preto (Faceres) instacron:FACERES |
instname_str |
Faculdade de Medicina em São José do Rio Preto (Faceres) |
instacron_str |
FACERES |
institution |
FACERES |
reponame_str |
MedNEXT Journal of Medical and Health Sciences |
collection |
MedNEXT Journal of Medical and Health Sciences |
repository.name.fl_str_mv |
MedNEXT Journal of Medical and Health Sciences - Faculdade de Medicina em São José do Rio Preto (Faceres) |
repository.mail.fl_str_mv |
mednextjmhs@zotarellifilhoscientificworks.com |
_version_ |
1822181998217658368 |
dc.identifier.doi.none.fl_str_mv |
10.54448/mdnt22S104 |